Click for best price
AntibodyDrug Conjugation Service Market Size, Share 2024
The global Antibody-Drug Conjugation Service market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Antibody Services Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Antibody-Drug Conjugation Service include BOC Sciences, Abzena, Creative Biolabs, WuXi XDC, Merck KGaA, Piramal, Charles River, Syngene and Novasep, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Antibody-Drug Conjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody-Drug Conjugation Service. This report contains market size and forecasts of Antibody-Drug Conjugation Service in global, including the following market information:
Global Antibody-Drug Conjugation Service Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Antibody-Drug Conjugation Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibody-Drug Conjugation Service Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Antibody-Drug Conjugation Service Market Segment Percentages, by Type, 2023 (%)
Antibody Services
Payload Services
Linker Services
Other
Global Antibody-Drug Conjugation Service Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Antibody-Drug Conjugation Service Market Segment Percentages, by Application, 2023 (%)
Breast Cancer
Lymphoma
Other
Global Antibody-Drug Conjugation Service Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Antibody-Drug Conjugation Service Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antibody-Drug Conjugation Service revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Antibody-Drug Conjugation Service revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
BOC Sciences
Abzena
Creative Biolabs
WuXi XDC
Merck KGaA
Piramal
Charles River
Syngene
Novasep
Seagen
Levena Biopharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antibody-Drug Conjugation Service, market overview.
Chapter 2: Global Antibody-Drug Conjugation Service market size in revenue.
Chapter 3: Detailed analysis of Antibody-Drug Conjugation Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antibody-Drug Conjugation Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antibody-Drug Conjugation Service Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antibody-Drug Conjugation Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antibody-Drug Conjugation Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antibody-Drug Conjugation Service Overall Market Size
2.1 Global Antibody-Drug Conjugation Service Market Size: 2023 VS 2030
2.2 Global Antibody-Drug Conjugation Service Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antibody-Drug Conjugation Service Players in Global Market
3.2 Top Global Antibody-Drug Conjugation Service Companies Ranked by Revenue
3.3 Global Antibody-Drug Conjugation Service Revenue by Companies
3.4 Top 3 and Top 5 Antibody-Drug Conjugation Service Companies in Global Market, by Revenue in 2023
3.5 Global Companies Antibody-Drug Conjugation Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibody-Drug Conjugation Service Players in Global Market
3.6.1 List of Global Tier 1 Antibody-Drug Conjugation Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Antibody-Drug Conjugation Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antibody-Drug Conjugation Service Market Size Markets, 2023 & 2030
4.1.2 Antibody Services
4.1.3 Payload Services
4.1.4 Linker Services
4.1.5 Other
4.2 By Type - Global Antibody-Drug Conjugation Service Revenue & Forecasts
4.2.1 By Type - Global Antibody-Drug Conjugation Service Revenue, 2019-2024
4.2.2 By Type - Global Antibody-Drug Conjugation Service Revenue, 2025-2030
4.2.3 By Type - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antibody-Drug Conjugation Service Market Size, 2023 & 2030
5.1.2 Breast Cancer
5.1.3 Lymphoma
5.1.4 Other
5.2 By Application - Global Antibody-Drug Conjugation Service Revenue & Forecasts
5.2.1 By Application - Global Antibody-Drug Conjugation Service Revenue, 2019-2024
5.2.2 By Application - Global Antibody-Drug Conjugation Service Revenue, 2025-2030
5.2.3 By Application - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Antibody-Drug Conjugation Service Market Size, 2023 & 2030
6.2 By Region - Global Antibody-Drug Conjugation Service Revenue & Forecasts
6.2.1 By Region - Global Antibody-Drug Conjugation Service Revenue, 2019-2024
6.2.2 By Region - Global Antibody-Drug Conjugation Service Revenue, 2025-2030
6.2.3 By Region - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Antibody-Drug Conjugation Service Revenue, 2019-2030
6.3.2 US Antibody-Drug Conjugation Service Market Size, 2019-2030
6.3.3 Canada Antibody-Drug Conjugation Service Market Size, 2019-2030
6.3.4 Mexico Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Antibody-Drug Conjugation Service Revenue, 2019-2030
6.4.2 Germany Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.3 France Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.4 U.K. Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.5 Italy Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.6 Russia Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.7 Nordic Countries Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.8 Benelux Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Antibody-Drug Conjugation Service Revenue, 2019-2030
6.5.2 China Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5.3 Japan Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5.4 South Korea Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5.5 Southeast Asia Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5.6 India Antibody-Drug Conjugation Service Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Antibody-Drug Conjugation Service Revenue, 2019-2030
6.6.2 Brazil Antibody-Drug Conjugation Service Market Size, 2019-2030
6.6.3 Argentina Antibody-Drug Conjugation Service Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antibody-Drug Conjugation Service Revenue, 2019-2030
6.7.2 Turkey Antibody-Drug Conjugation Service Market Size, 2019-2030
6.7.3 Israel Antibody-Drug Conjugation Service Market Size, 2019-2030
6.7.4 Saudi Arabia Antibody-Drug Conjugation Service Market Size, 2019-2030
6.7.5 UAE Antibody-Drug Conjugation Service Market Size, 2019-2030
7 Antibody-Drug Conjugation Service Companies Profiles
7.1 BOC Sciences
7.1.1 BOC Sciences Company Summary
7.1.2 BOC Sciences Business Overview
7.1.3 BOC Sciences Antibody-Drug Conjugation Service Major Product Offerings
7.1.4 BOC Sciences Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.1.5 BOC Sciences Key News & Latest Developments
7.2 Abzena
7.2.1 Abzena Company Summary
7.2.2 Abzena Business Overview
7.2.3 Abzena Antibody-Drug Conjugation Service Major Product Offerings
7.2.4 Abzena Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.2.5 Abzena Key News & Latest Developments
7.3 Creative Biolabs
7.3.1 Creative Biolabs Company Summary
7.3.2 Creative Biolabs Business Overview
7.3.3 Creative Biolabs Antibody-Drug Conjugation Service Major Product Offerings
7.3.4 Creative Biolabs Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.3.5 Creative Biolabs Key News & Latest Developments
7.4 WuXi XDC
7.4.1 WuXi XDC Company Summary
7.4.2 WuXi XDC Business Overview
7.4.3 WuXi XDC Antibody-Drug Conjugation Service Major Product Offerings
7.4.4 WuXi XDC Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.4.5 WuXi XDC Key News & Latest Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Company Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Antibody-Drug Conjugation Service Major Product Offerings
7.5.4 Merck KGaA Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.5.5 Merck KGaA Key News & Latest Developments
7.6 Piramal
7.6.1 Piramal Company Summary
7.6.2 Piramal Business Overview
7.6.3 Piramal Antibody-Drug Conjugation Service Major Product Offerings
7.6.4 Piramal Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.6.5 Piramal Key News & Latest Developments
7.7 Charles River
7.7.1 Charles River Company Summary
7.7.2 Charles River Business Overview
7.7.3 Charles River Antibody-Drug Conjugation Service Major Product Offerings
7.7.4 Charles River Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.7.5 Charles River Key News & Latest Developments
7.8 Syngene
7.8.1 Syngene Company Summary
7.8.2 Syngene Business Overview
7.8.3 Syngene Antibody-Drug Conjugation Service Major Product Offerings
7.8.4 Syngene Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.8.5 Syngene Key News & Latest Developments
7.9 Novasep
7.9.1 Novasep Company Summary
7.9.2 Novasep Business Overview
7.9.3 Novasep Antibody-Drug Conjugation Service Major Product Offerings
7.9.4 Novasep Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.9.5 Novasep Key News & Latest Developments
7.10 Seagen
7.10.1 Seagen Company Summary
7.10.2 Seagen Business Overview
7.10.3 Seagen Antibody-Drug Conjugation Service Major Product Offerings
7.10.4 Seagen Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.10.5 Seagen Key News & Latest Developments
7.11 Levena Biopharma
7.11.1 Levena Biopharma Company Summary
7.11.2 Levena Biopharma Business Overview
7.11.3 Levena Biopharma Antibody-Drug Conjugation Service Major Product Offerings
7.11.4 Levena Biopharma Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.11.5 Levena Biopharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antibody-Drug Conjugation Service Market Opportunities & Trends in Global Market
Table 2. Antibody-Drug Conjugation Service Market Drivers in Global Market
Table 3. Antibody-Drug Conjugation Service Market Restraints in Global Market
Table 4. Key Players of Antibody-Drug Conjugation Service in Global Market
Table 5. Top Antibody-Drug Conjugation Service Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Antibody-Drug Conjugation Service Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Antibody-Drug Conjugation Service Revenue Share by Companies, 2019-2024
Table 8. Global Companies Antibody-Drug Conjugation Service Product Type
Table 9. List of Global Tier 1 Antibody-Drug Conjugation Service Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody-Drug Conjugation Service Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Antibody-Drug Conjugation Service Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Antibody-Drug Conjugation Service Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Antibody-Drug Conjugation Service Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Antibody-Drug Conjugation Service Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Antibody-Drug Conjugation Service Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Antibody-Drug Conjugation Service Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2025-2030
Table 30. BOC Sciences Company Summary
Table 31. BOC Sciences Antibody-Drug Conjugation Service Product Offerings
Table 32. BOC Sciences Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 33. BOC Sciences Key News & Latest Developments
Table 34. Abzena Company Summary
Table 35. Abzena Antibody-Drug Conjugation Service Product Offerings
Table 36. Abzena Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 37. Abzena Key News & Latest Developments
Table 38. Creative Biolabs Company Summary
Table 39. Creative Biolabs Antibody-Drug Conjugation Service Product Offerings
Table 40. Creative Biolabs Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 41. Creative Biolabs Key News & Latest Developments
Table 42. WuXi XDC Company Summary
Table 43. WuXi XDC Antibody-Drug Conjugation Service Product Offerings
Table 44. WuXi XDC Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 45. WuXi XDC Key News & Latest Developments
Table 46. Merck KGaA Company Summary
Table 47. Merck KGaA Antibody-Drug Conjugation Service Product Offerings
Table 48. Merck KGaA Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 49. Merck KGaA Key News & Latest Developments
Table 50. Piramal Company Summary
Table 51. Piramal Antibody-Drug Conjugation Service Product Offerings
Table 52. Piramal Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 53. Piramal Key News & Latest Developments
Table 54. Charles River Company Summary
Table 55. Charles River Antibody-Drug Conjugation Service Product Offerings
Table 56. Charles River Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 57. Charles River Key News & Latest Developments
Table 58. Syngene Company Summary
Table 59. Syngene Antibody-Drug Conjugation Service Product Offerings
Table 60. Syngene Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 61. Syngene Key News & Latest Developments
Table 62. Novasep Company Summary
Table 63. Novasep Antibody-Drug Conjugation Service Product Offerings
Table 64. Novasep Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 65. Novasep Key News & Latest Developments
Table 66. Seagen Company Summary
Table 67. Seagen Antibody-Drug Conjugation Service Product Offerings
Table 68. Seagen Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 69. Seagen Key News & Latest Developments
Table 70. Levena Biopharma Company Summary
Table 71. Levena Biopharma Antibody-Drug Conjugation Service Product Offerings
Table 72. Levena Biopharma Antibody-Drug Conjugation Service Revenue (US$, Mn) & (2019-2024)
Table 73. Levena Biopharma Key News & Latest Developments
List of Figures
Figure 1. Antibody-Drug Conjugation Service Segment by Type in 2023
Figure 2. Antibody-Drug Conjugation Service Segment by Application in 2023
Figure 3. Global Antibody-Drug Conjugation Service Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Antibody-Drug Conjugation Service Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Antibody-Drug Conjugation Service Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antibody-Drug Conjugation Service Revenue in 2023
Figure 8. By Type - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 9. By Application - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 10. By Type - Global Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 12. By Application - Global Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 14. By Region - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 15. By Country - North America Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 16. US Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 20. Germany Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 21. France Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 28. China Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 32. India Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 34. Brazil Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
Figure 37. Turkey Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Antibody-Drug Conjugation Service Revenue, (US$, Mn), 2019-2030
Figure 41. BOC Sciences Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Abzena Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Creative Biolabs Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. WuXi XDC Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Merck KGaA Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Piramal Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Charles River Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Syngene Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Novasep Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Seagen Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Levena Biopharma Antibody-Drug Conjugation Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
